Rubino DM, Greenway FL, Khalid U, ONeil PM, Rosenstock J, Srrig R, et al
Theres no proof these drugs harm your eye on their own
The FDA has approved three GLP-1s in particular for both type 2 diabetes treatment and weight loss: Liraglutide (Saxenda, Victoza): While effective, this once-daily injection generally leads to more modest weight loss compared to newer options (its been around since 2014)
Johns, M
Local Common (1% to 10%): Injection site reactions (subcutaneous formulation) Injection site reactions included administration site reactions, application/instillation site reactions, erythema, induration, inflammation, infusion site reactions, injection site discomfort, injection site pruritus, injection site rash, and irritation